Scarica l'app Stockscreener
0.84
7.69%
0.06
Dopo l'orario di chiusura:
.82
-0.02
-2.38%
Precedente Chiudi:
$0.78
Aprire:
$0.81
Volume 24 ore:
57,444
Relative Volume:
0.50
Capitalizzazione di mercato:
$46.67M
Reddito:
-
Utile/perdita netta:
$-21.38M
Rapporto P/E:
-2.1538
EPS:
-0.39
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
+11.26%
1M Prestazione:
+3.70%
6M Prestazione:
-20.75%
1 anno Prestazione:
-46.33%
Intervallo 1D:
$0.7818
$0.84
Intervallo di 1 settimana:
$0.75
$0.84
Portata 52W:
$0.51
$2.0699
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile
Nome
Connect Biopharma Holdings Ltd Adr
Settore
Industria
Telefono
858-727-1040
Indirizzo
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Confronta CNTB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd Adr
|
0.84 | 41.95M | 0 | -21.38M | -25.19M | -0.39 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-13 | Iniziato | Jefferies | Buy |
| 2021-04-13 | Iniziato | Piper Sandler | Overweight |
| 2021-04-13 | Iniziato | SVB Leerink | Outperform |
Connect Biopharma Holdings Ltd Adr Borsa (CNTB) Ultime notizie
Connect Biopharma begins Phase 2 asthma study - Investing.com
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com
FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com
Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com
Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India
Connect Biopharma faces Nasdaq delisting over share price - Investing.com
Connect Biopharma stock hits 52-week low at $0.76 - Investing.com
Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
Top 3 Aerospace and Defense Stocks Flying Under the Radar - The Globe and Mail
CPIX Stock Quote Price and Forecast - CNN
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - USC-China Institute
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
Connect Biopharma Holdings Limited: Shareholders Board Members Managers and Company Profile | US2075231017 - Marketscreener.com
CNTB News Today | Why did Connect Biopharma stock go up today? - MarketBeat
Connect Biopharma Holdings Ltd Adr Azioni (CNTB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):